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Abstract
Endogenous endophthalmitis (EE) is a rare but devastating infection that occurs secondary to seeding of the
intraocular cavity from an extraocular focus. Recent reports suggest the increasing prevalence and incidence of
Klebsiella pneumoniae as a causative organism in Asian countries. Analysis of the largest cohorts published to date
suggests that K. pneumoniae endogenous endophthalmitis (KPEE) is 10 to 15 times more prevalent than other
causes of EE. The incidence of KPEE among patients with systemic Klebsiella infection appears to be >100-fold more
common than other causes of EE. The exact reason for these observations is not clear, but a number of studies
now suggest that Klebsiella serotypes K1 and K2 have virulence factors that enhance their survival in diabetic
patients and increase their pathogenicity. Here, we report two cases of KPEE in the USA. We also review the recent
clinical and basic science literature on the prevalence, incidence, and pathophysiology of this emerging and
devastating infection.
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Introduction
Endogenous endophthalmitis (EE) is a relatively uncom-
mon but severe infection that comprises 2% to 15% of
all cases of endophthalmitis [1-3]. It is commonly asso-
ciated with underlying immunosuppression including
diabetes mellitus, cardiac disease, renal insufficiency and
malignancy. While a number of organisms have been
implicated in EE, Klebsiella pneumoniae has been recog-
nized as an increasingly prevalent cause of EE in the
Asian population [1,2,4-12]. In addition to numerous
case series from Asia, a growing body of basic scientific
research has begun to elucidate the pathophysiology of
this particular infection. In this case series and review,
we report two cases of systemic Klebsiella infection that
resulted in EE within the USA. We also discuss recent
literature that is starting to shed light on the epidemi-
ology and pathophysiology of this condition.
Epidemiology
The clinical experience with K. pneumoniae endogenous
endophthalmitis (KPEE) is varied, and comparison of the
numerous retrospective studies is difficult due to differ-
ences in the methods and reporting criteria [1]. Neverthe-
less, several large retrospective studies report a surprisingly
high number of cases of KPEE among patients with EE
(Table 1). Wong et al. reported a series of 27 patients with
bacterial EE from Singapore over a 4-year period [6]. Sixty
percent of cases were secondary to K. pneumoniae,a n d
48% of these had hepatobiliary sources of infection. Chen
et al. reported 74 patients with EE from Taiwan over a 10-
year period [5]. Sixty-one percent of cases were secondary
to K. pneumoniae, and 53% of these cases had liver abscess.
Ang et al. reported 113 patients with EE from Singapore
over a 21-year period [9]. Sixty-one patients (54%) and 71
eyes had KPEE. These studies demonstrate that among
patients with EE in Asia, the prevalence of KPEE is high
(54% to 61%; Table 1). In contrast, Jackson et al. reported a
series of 21 eyes in 19 patients with EE from England over
a 17-year period, and only one case was secondary to Kleb-
siella (5% prevalence) [1]. Similarly, Okada et al. reviewed
all cases of EE admitted to the Massachusetts Eye and Ear
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year period. They found 28 patients with the diagnosis of
EE, and only one case was due to Klebsiella (prevalence
3.6%) [3]. Table 1 summarizes these studies.
The reason for this high prevalence in Asia is not clear.
Some data suggest that Asian populations have a high
prevalence of Klebsiella bacteremia and that K. pneumo-
niae is particularly more likely to cause EE than other
organisms. Sheu et al. reported a series from Taiwan of
602 patients admitted with K. pneumoniae liver abscess
over an 18-year period [13]. Forty-two patients (7%) and
53 eyes developed KPEE. Fifty-three percent of these
patients had diabetes. Sng et al. reported a case-controlled
study of 133 patients with Klebsiella bacteremia from
Singapore over a 1-year period [4]. KPEE was reported in
five (3.8%) of these patients, and two cases were bilateral.
All cases with KPEE were associated with liver abscess.
Yang et al. reported a series of 200 patients with K. pneu-
moniae liver abscess admitted to aTaiwanese hospital over
a 17-year period [14]. Twenty-seven eyes of 22 patients
(11%) developed KPEE, and 68% of these had diabetes
mellitus. These studies suggest that the incidence of KPEE
among patients with systemic Klebsiella infection is 3% to
11% (Table 2). This rate of ocular involvement among
patients with systemic Klebsiella infection is much higher
than ocular involvement in other systemic infections. For
example, Jackson et al. reviewed 5,859 cases of all-cause
bacteremia at St. Thomas Hospital (England) and reported
EE in 19 patients (incidence of <0.01%) [1]. Table 2 sum-
marizes these data.
The incidence and prevalence calculations above sug-
gest that KPEE warrants further investigation. In fact, a
number of studies have specifically looked at the patho-
physiology of this particular infection. The findings have
been revealing about the mechanisms of infection as
well as the particularly poor prognosis of this infection
versus other causes of endophthalmitis.
Clinical experience
The classic features of EE include ocular pain, blurred
vision, swollen eyelids, injection and chemosis, anterior
chamber inflammation, hypopyon, and elevated intrao-
cular pressure. Systemic disease is often advanced, and
patients are usually already hospitalized for bacteremia,
sepsis, or other systemic complications before the onset
of ocular symptoms. There is no consensus on treatment
although most studies suggest early and aggressive inter-
vention. A number of studies have reported the visual
outcome of KPEE after treatment. Unfortunately, almost
all large series and most case reports have very poor out-
comes. One case report [15] and one series [16] suggest
that very early vitrectomy can preserve vision, but most
studies report very poor outcomes regardless of specific
interventions.
For example, Yang et al. reviewed the risk factors, clin-
ical features, and visual outcomes in patients with KPEE
Table 1 Reported prevalence of KPEE among EE in Asian and non-Asian countries
Study Date range and location Number of EE cases Prevalence of KPEE among EE (%)
Asian studies Wong et al. [6] 1994 to 1997; Singapore 27 60
Chen et al. [5] 1992 to 2002; Taiwan 74 61
Ang et al. [9] 1986 to 2007; Singapore 113 54
Average prevalence in Asian countries 58
Non-Asian studies Jackson et al. [1] 1984 to 2001; England 19 5
Okada et al. [3] 1980 to 1990; USA 28 3.6
Average prevalence in western countries 4.3
Table 2 Incidence of EE and KPEE among cases of systemic infection
Study Date and
location
Cases of
systemic K.
pneumoniae
infection
Incidence of
KPEE among
K. pneumoniae
systemic disease
Study Date and
location
Cases of
systemic
all-cause
bacteremia
Incidence
of EE
Asian studies Sheu et al. [11] 1991 to 2009;
Taiwan
602 7% Non-Asian
studies
Jackson
et al. [1]
1984 to 2001;
England
5,859 <0.01%
a
Sng et al. [4] 2004 to 2005;
Singapore
133 3.8%
Yang et al. [12] 1994 to 2001;
Taiwan
200 11%
Average incidence of
KPEE in Asian countries
7.3%
aThis is the only study available that reports on the prevalence of EE among a cohort of patients with systemic bacteremia.
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200 patients with K. pneumoniae liver abscess, 22 con-
secutive patients with KPEE were reported during an 8-
year period. Twenty-three percent of patients had bilateral
involvement, and 68% of these had diabetes. Despite ag-
gressive treatment, final visual acuity of light perception
or worse occurred in 89% of patients of which 41% were
eventually eviscerated or enucleated [14].
Similarly, Yoon et al. reviewed seven cases of KPEE.
Five patients (71%) had diabetes, and four patients (57%)
had liver abscess. Eight percent of eyes had hand-motion
vision or worse on presentation. After aggressive treat-
ment including pars plana vitrectomy, 70% of eyes had
count fingers vision or worse. However, three eyes had
vision better than count fingers, and in all eyes, the ret-
ina remained attached throughout 6 months of follow-
up [16].
We have previously described an atypical case of KPEE
[26] that presented with bilateral intraocular inflamma-
tion without hypopyon, and systemic evaluation revealed
a widely disseminated infection. In the next subsections,
we summarize our experience with two additional cases
of KPEE with interesting atypical features that merit
attention.
Atypical case report 1
A 54-year-old Vietnamese man was referred with pain in
the right eye. There was no history of trauma or surgery.
He had undergone vitreous tap and injection at an out-
side facility for presumed endophthalmitis. The patient’s
past medical history was significant for hypertension.
Visual acuity was counting fingers in the right eye and
20/25 in the left eye. There was less than 1 mm of
hypopyon in the right eye and dense vitritis. The patient
was admitted for presumed EE and underwent immedi-
ate vitrectomy. In addition to vitreous inflammation, the
superior temporal retina was necrotic. The quadrant of
retinitis was demarcated with laser, and intravitreal
vancomycin and ceftazidime were administered. Cultures
of aspirated vitreous debris grew K. pneumoniae. Sys-
temic evaluation revealed K. pneumoniae liver abscess.
The patient responded well to systemic and ocular ther-
apies. Although this case had a typical presentation and
course, it is remarkable in that the final visual acuity in
the right eye was 20/30. There are very few reports of
such good outcomes associated with KPEE, and to date,
the reasons for these outcomes are not clear.
Atypical case report 2
A 47-year-old Hispanic man originally from Mexico was
referred for evaluation of uveitis of unknown cause. The
patient had been living in Los Angeles for the past 24
years. The patient experienced fever and chills 3 weeks
prior and subsequently noticed blurry vision in his left
eye 2 weeks prior to presentation. The patient denied
any previous ocular disease or trauma. The patient was
seen by an outside physician and started on oral Bactrim
for presumed prostatitis shortly after the onset of his
systemic symptoms. The patient was also seen by an
ophthalmologist and started on atropine twice a day OS,
prednisolone acetate every hour OS, and oral prednisone
30 mg/day for presumed uveitis. Review of systems was
significant for 20- to 30-lb weight loss in the month pre-
ceding presentation. The patient’s past medical history
was notable for hypertension. The patient denied any
drug use, smoking, or travel besides a recent trip to
Texas, Arizona, and Mexico.
Visual acuity was 20/80 in the right eye and hand mo-
tion in the left eye. Intraocular pressures were normal.
Examination of the right eye was unremarkable for any
acute process. The left eye demonstrated mild conjunc-
tival injection and chemosis, and a 1.5-mm layered
hypopyon. Pigmented debris was noted on the anterior
lens capsule. The left fundus revealed moderate vitreous
haze, some layered vitreous debris inferiorly and mul-
tiple large, white retinal lesions involving the macula.
This case was remarkable in that ultrasound revealed a
subretinal abscess with vitreous strands and debris.
The patient was diagnosed with EE secondary to pre-
sumed UTI and he received intravitreal tap and injection
of vancomycin, ceftazidime, and voriconazole. He was
tapered off the oral steroids and admitted for immediate
systemic treatment. Serum glucose levels were elevated
(322 mg/dL) as was the hemoglobin A1c (8.7). Other
labs were significant including elevated WBC (12.6), ele-
vated CRP (2.5), positive MHA-TP, negative RPR, and
negative human immunodeficiency virus (HIV). He was
started on intravenous vancomycin and ceftazidime. The
patient underwent pars plana vitrectomy and lensectomy
with drainage of subretinal abscess. Material from the
vitreous and subretinal abscess grew K. pneumoniae.
Urine culture was positive for K. pneumoniae. The patient
was discharged on home IV ceftriaxone, oral metronida-
zole, and oral levofloxacin for 4 to 6 weeks. The left eye
ultimately developed light perception vision and a total
retinal detachment. While this case has a typical course
and outcome for KPEE, it is unusual in that the infection
involved a subretinal abscess.
Pathophysiology
It is well known that patients with EE usually have comor-
bid immunocompromising diseases such as diabetes, HIV
infection, indwelling catheters, renal failure, cardiac dis-
ease, malignancy, or immunosuppressive therapy. KPEE
occurs secondary to hematogenous dissemination from an
extraocular focus (usually liver) and is rarely associated
with surgery or trauma. The ‘Endophthalmitis Vitrectomy
Study’ reported that only 5.9% of culture-positive cases
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to Klebsiella [17]. Only one case series that we could find
reported Klebsiella endophthalmitis secondary to cataract
surgery, trauma, or other causes [18].
In addition to host immunosuppression, Klebsiella-
specific virulence factors have been implicated in the
pathogenicity of this organism. K. pneumoniae is an en-
teric, gram-negative bacillus with a polysaccharide cap-
sule. The composition of the cell surface antigens on the
capsule are used to classify Klebsiella organisms into ser-
otypes. Organisms with capsule serotype K1 or K2 seem
to predominate in cases of liver abscess and metastatic
spread to other organs including the eye [19,20]. Of the
several serotypes (K1, K2, K5, K20, K54, K57, among
others) that have been identified, multiple lines of evi-
dence support the increased virulence of organisms with
K1 or K2 serotypes. For example, capsular serotypes K1
and K2 inhibit phagocytosis by neutrophils isolated from
diabetic patients in vitro [21]. In addition, K1 isolates
show significantly higher serum resistance and decreased
susceptibility to intracellular destruction by neutrophils
than other Klebsiella serotypes [20]. A single intraperito-
neal injection of human neutrophils containing phagocy-
tosed K1 K. pneumoniae leads to abscess formation in
multiple sites in mice, whereas non-K1 serotypes do not
demonstrate this ability [20]. This suggests that there
may be a role for capsular phenotype testing in patients
with Klebsiella bacteremia. Currently, capsular pheno-
typing is available in the USA, but it is not commonly
performed [22-25]. We recently reported one case of bi-
lateral KPEE with widespread disseminated systemic in-
fection with confirmed K1 capsular serotype in the USA
(see the ‘Clinical experience’ section) [26]. To our know-
ledge, no other cases of Klebsiella endophthalmitis with
verified K1 serotype have been reported in the USA.
The K1 and K2 serotypes are associated with geno-
types which may confer some of their virulence. Specif-
ically, the magA gene (mucoviscosity-associated gene
A or capsular polymerase Wzy(KpK1) [27]) and rmpA
gene (regulator of the mucoid phenotype) have been
found in the K1 and K1/K2 serotypes, respectively [28].
The specific roles of these genes in the pathophysiology
of endophthalmitis has yet to be determined, but a re-
cent study in mice showed that the hypermucoviscous
K. pneumoniae associated with the K1 serotype is asso-
ciated with more rapid development of phthisis, more
pronounced inflammation, and poor recovery of retinal
function compared with a control strain [28]. A recent
study demonstrates that wild-type magA+ and trans-
complemented magA organisms grow more rapidly and
cause a more profound decrease in ERG a- and b-waves
and cellular infiltration in a mouse model than the
magA deficient organism [29]. This study is notable in
that the organisms lack any hemolytic or proteolytic
toxins [29]. Interestingly, wild-type K. pneumoniae
(magA+) causes a more inflammatory response (as mea-
sured by myeloperoxidase assay) than trans-complemented
magA organisms, suggesting additional virulence factors in
the wild-type organisms or a pathologic difference in the
trans-complemented organism [29]. Analysis of various
growth media conditioned by K. pneumoniae seems to
suggest that a secreted factor(s) may also be involved in
Klebsiella virulence [11,30]. Systemically, the lethal dose
of magA-positive strains in a mouse model was approxi-
mately 4 to 5 log units lower than isogenic mutants defi-
cient for magA [19,31,32]. Clinically, both the K1 and K2
serotypes have been associated with a hypermucoviscous
(HMV) phenotype. This phenotype is defined by the for-
mation of a mucoviscous string greater than 5 mm when
a standard bacteriological loop is passed through a colony
[28]. It appears that the HMV phenotype overlaps with
the K1/K2 serotypes and is significantly associated with
bacteremia and invasive infections including meningitis
and endophthalmitis [33]. The risk for metastatic spread
to the eye or the CNS with primary Klebsiella abscess is
noted to be 3% to 10% [34,35]; however, at least 50% of
patients with Klebsiella endophthalmitis have an under-
lying liver abscess caused by the same bacteria [1]. The
poor response of KPEE to aggressive treatment is not well
u n d e r s t o o d .S o m ee v i d e n c es u g g e s tt h a tt h i sm a yb ed u e
to poor surveillance and late diagnosis [9]. For example,
our previously published case report [26] as well as a few
other studies have noted disseminated systemic infec-
tion within the first few days of presentation [13,36].
This suggests that widespread infection was already
present before ocular involvement in at least some
cases. Other factors may include antimicrobial resist-
ance. K. pneumoniae is well known for its resistance to
traditional and novel antibacterial agents including third-
generation cephalosporins, fluoroquinolones, carbape-
nems, and extended spectrum beta-lactamases.
Conclusions
The notably high incidence and prevalence of KPEE in
Asia has resulted in a number of informative studies
reviewed above. The high incidence of KPEE in patients
with systemic K. pneumoniae infection may provide a
model of EE which can facilitate further clinical studies
of this infection. These studies in conjunction with basic
science studies of the pathophysiology of K. pneumoniae
infection are allowing focused hypothesis testing of the
mechanism of EE. Therefore, further study of KPEE may
facilitate better diagnostic and therapeutic management
of endophthalmitis in general.
The data available suggest that patients with liver
abscess and immunocompromising conditions should be
watched closely for signs and symptoms of hematologic
spread and EE. These studies suggest a causal and
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siella infection and KPEE. Serotyping for the K1/K2-posi-
tive organisms may play an increasing role in determining
which patients are at highest risk. This information can
potentially lead to screening guidelines or prophylactic
treatment. Patients of Asian descent are at highest risk for
Klebsiella-related EE. However, it is not clear if this is due
to a genetic predisposition to infection among Asians or a
higher prevalence of virulent Klebsiella organisms in Asia.
The studies reviewed here suggest the latter possibility
since the polysaccharide capsule is protective against
phagocytosis and bactericidal serum factors. This report
also highlights the occurrence of KPEE in the USA in
patients with no known recent travel history to Asia. No
course of treatment has been clearly beneficial, but a few
cases where immediate, early treatment (within 24 h of
presentation) with pars plana vitrectomy and/or intravi-
treal antibiotics was performed preserved some degree of
useful vision [15].
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